Derek A. Wainwright
机构: Loyola University Chicago Stritch School of Medicine
主页: linkedin.com
每年引用次数
引用次数
引用: 6,917
H-指数: 40
I10-指数 : 77
出版物: 198
Reduced skin homing by functional Treg in vitiligo
Jared Klarquist , Cecele J. Denman , Claudia Hernandez , Derek J. Wainwright
Pigment Cell & Melanoma Research 23 ( 2) 276 -286
109
2010
Correction: Durable therapeutic efficacy utilizing combinatorial blockade against IDO, CTLA-4, and PD-L1 in mice with brain tumors
DA Wainwright , AL Chang , M Dey , IV Balyasnikova
Clinical Cancer Research 21 ( 3) 662 -662
1
2015
Functional cloning of a gp100-reactive TCR from depigmenting vitiligo skin
J Klarquist , M Li , DA Wainwright , RM Luiten
PIGMENT CELL & MELANOMA RESEARCH 24 ( 4) 802 -803
2011
INVESTIGATION OF CHEMOKINES RESPONSIBLE FOR CD4+ T CELL-MEDIATED NEUROPROTECTION IN A MSOD1 MOUSE MODEL AND FACIAL NERVE AXOTOMY
KJ Jones , DA Wainwright , VM Sanders
JOURNAL OF NEUROCHEMISTRY 108 23 -23
2009
Investigation of CD4+ T cell-mediated neuroprotection in a mouse model of facial nerve axotomy
J Xin , DA Wainwright , NA Mesnard , VM Sanders
JOURNAL OF NEUROCHEMISTRY 104 28 -28
2008
IMPS-39IDO1: MORE THAN JUST AN ENZYME IN MALIGNANT GLIOMA
Derek Wainwright
Neuro-oncology 17
2015
IMPS-43IDO1 DOES NOT FUNCTION AS A TRYPTOPHAN CATABOLIC ENZYME IN MALIGNANT GLIOMA
Lijie Zhai , Kristen Lauing , Jun Qian , Galina Gritsina
Neuro-oncology 17
2015
HOUT-10. SELECTIVE SEROTONIN REUPTAKE INHIBITOR (SSRI) TREATMENT IS ASSOCIATED WITH IMPROVED SURVIVAL AMONG ELDERLY PATIENTS DIAGNOSED WITH GLIOBLASTOMA
Sebastian Otto-Meyer , Erik Ladomersky , Denise Scholtens , Lijie Zhai
Neuro-oncology 20
2018
IMMU-10. RADIOTHERAPY AND PD-1 BLOCKADE INCREASES TRYPTOPHAN METABOLISM IN BRAIN TUMOR-DRAINING SECONDARY LYMPHOID ORGANS
Rohan Savoor , Erik Ladomersky , Sebastian Otto-Meyer , Lijie Zhai
Neuro-oncology 20
2018
IMMU-41. IDO1 INCREASES Treg RECRUITMENT INDEPENDENT OF TRYPTOPHAN METABOLISM IN A MODEL OF GLIOBLASTOMA
Lijie Zhai , Jun Qian , Erik Ladomersky , Kristen Lauing
Neuro-oncology 20
2018
IMMU-46. GLIOBLASTOMA PATIENT DIAGNOSES AND IMMUNOSUPPRESSION ARE MAXIMAL DURING OLD AGE: A RANDOM COINCIDENCE, OR CAUSE AND EFFECT?
Erik Ladomersky , Sebastian Otto-Meyer , Lijie Zhai , Rohan Savoor
Neuro-oncology 20
2018
IMMU-35. PSYCHOSOCIAL STRESS NEGATIVELY IMPACTS IMMUNOTHERAPY IN IMMUNOCOMPETENT MODELS OF GLIOBLASTOMA
Erik Ladomersky , Sebastian Otto-Meyer , Lijie Zhai , Rohan Savoor
Neuro-oncology 20
2018
IMMU-34. A BALANCED TRYPTOPHAN DIET LEADS TO MAXIMAL IMMUNOTHERAPEUTIC EFFICACY IN GLIOBLASTOMA MODELS
Erik Ladomersky , Lijie Zhai , Alicia Lenzen , Kristen Lauing
Neuro-oncology 20
2018
CBMT-34. MODULATING DIETARY TRYPTOPHAN OR GUT MICROBIOTA LEVELS DOES NOT IMPROVE THE EFFICACY OF COMBINED TREATMENT WITH RADIATION, ANTI-PD-1 mAb, AND AN IDO1 ENZYME INHIBITOR IN A MODEL OF GLIOBLASTOMA
Erik Ladomersky , Lijie Zhai , Kristen Lauing , Jun Qian
Neuro-oncology 21
2019
HOUT-20. TIME-DEPENDENT ANALYSIS OF SELECTIVE SEROTONIN REUPTAKE INHIBITOR TREATMENT ON OVERALL SURVIVAL OF PATIENTS WITH GLIOBLASTOMA
Sebastian Otto-Meyer , Rian DeFaccio , Corey Dussold , Erik Ladomersky
Neuro-oncology 21
2019
IMMU-22. TARGETING NON-CANONICAL FUNCTION OF IDO1 IN GLIOBLASTOMA IMMUNOTHERAPY
Lijie Zhai , April Bell , Jun Qian , Erik Ladomersky
Neuro-oncology 21
2019
IMMU-20. ADVANCED AGING INCREASES IMMUNOSUPPRESSIVE IDO1 LEVELS THAT ARE UNINHIBITED BY IDO1 ENZYME INHIBITOR TREATMENT IN MODELS OF GLIOBLASTOMA
Erik Ladomersky , Lijie Zhai , Kristen Lauing , Jun Qian
Neuro-oncology 21
2019
IMMU-44. INHIBITING IMMUNOSUPPRESSIVE IDO1 IN ADULTS WITH MALIGNANT GLIOMA – A MOVING TARGET THAT CHANGES WITH TREATMENT, CELL OF ORIGIN, AND AGING
Erik Ladomersky , Lijie Zhai , Kristen Lauing , Jun Qian
Neuro-oncology 21
2019
DDRE-09. DEVELOPING IDO-PROTACS TO IMPROVE IMMUNOTHERAPEUTIC EFFICACY IN PATIENTS WITH GLIOBLASTOMA
Lakshmi Bollu , Derek Wainwright , Lijie Zhai , Erik Ladomersky
Neuro-oncology 22
2020
EXTH-45. DELTA-24-RGDOX ACTIVATION OF THE IDO-KYN-AHR CASCADE IN GLIOBLASTOMA: OLD TARGETS FOR A NEW THERAPY
Teresa Nguyen , Dong Ho Shin , Hong Jiang , Derek Wainwright
Neuro-oncology 22
2020